Herborium Group Stock Fundamentals
| HBRMDelisted Stock | USD 0.0001 0.00 0.00% |
Herborium Group fundamentals help investors to digest information that contributes to Herborium's financial success or failures. It also enables traders to predict the movement of Herborium Pink Sheet. The fundamental analysis module provides a way to measure Herborium's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Herborium pink sheet.
Herborium |
Herborium Group Company Current Valuation Analysis
Herborium's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Herborium Current Valuation | 220.29 K |
Most of Herborium's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Herborium Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Herborium Group has a Current Valuation of 220.29 K. This is 100.0% lower than that of the Personal Products sector and significantly higher than that of the Consumer Staples industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Herborium Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Herborium's current stock value. Our valuation model uses many indicators to compare Herborium value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Herborium competition to find correlations between indicators driving Herborium's intrinsic value. More Info.Herborium Group is one of the top stocks in profit margin category among its peers. It also is one of the top stocks in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Herborium's earnings, one of the primary drivers of an investment's value.Herborium Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Herborium's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Herborium could also be used in its relative valuation, which is a method of valuing Herborium by comparing valuation metrics of similar companies.Herborium is currently under evaluation in current valuation category among its peers.
Herborium Fundamentals
| Profit Margin | 0.26 % | ||||
| Operating Margin | (0.98) % | ||||
| Current Valuation | 220.29 K | ||||
| Shares Outstanding | 2.2 B | ||||
| Price To Sales | 2.55 X | ||||
| Revenue | 908.6 K | ||||
| Gross Profit | 125.4 K | ||||
| EBITDA | (250.2 K) | ||||
| Net Income | (32.2 K) | ||||
| Cash And Equivalents | 120.1 K | ||||
| Cash Per Share | 0.20 X | ||||
| Total Debt | 290 K | ||||
| Book Value Per Share | (2.03) X | ||||
| Cash Flow From Operations | 29.6 K | ||||
| Earnings Per Share | 0.12 X | ||||
| Beta | 89.84 | ||||
| Market Capitalization | 220.29 K | ||||
| Total Asset | 187.6 K | ||||
| Retained Earnings | (4.93 M) | ||||
| Working Capital | (112 K) | ||||
| Current Asset | 63 K | ||||
| Current Liabilities | 175 K | ||||
| Z Score | -35.7 | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 187.6 K |
About Herborium Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Herborium Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Herborium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Herborium Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey. Herborium operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Herborium Pink Sheet
If you are still planning to invest in Herborium Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Herborium's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |